Buphenine or nylidrin

This classification denotes a beta-adrenergic agonist with the molecular formula C19H25NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 695DKH33EI, chemically known as benzyl alcohol, p-hydroxy-alpha-(1-((1-methyl-3-phenylpropyl)amino)ethyl)- but generally known as buphenine, which bears US NIH Compound Identifier 4567. Buphenine most often comes in base and hydrochloride forms. European Medicines Agency schedules Buphenine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05981MIG. The term BUPHENINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules buphenine in its Anatomical Therapeutic Chemical (ATC) Classification. BUPHENINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Buphenine or nylidrin bears US NLM identifiers UMLS ID C0028735 and NCI Concept Code C81642. SMILES: OC(C(NC(CCc1ccccc1)C)C)c1ccc(O)cc1.